kt 5823 has been researched along with syntide-2 in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (syntide-2) | Trials (syntide-2) | Recent Studies (post-2010) (syntide-2) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 37 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Granger, HJ; Hood, J | 1 |
1 other study(ies) available for kt 5823 and syntide-2
| Article | Year |
|---|---|
Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells.
Topics: Alkaloids; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Division; Cells, Cultured; Cyclic GMP; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Signal Transduction; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |